Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Verano HoldingsVRNOD 73 EV-to-FCF is 19.82 as of Aug. 08, 2026, which is 44% below its 10-year median of 35.47. GuruFocus rates VRNOD with a GF Score™ of 73/100 and a GF Value™ of $6.60 (Modestly Undervalued). The stock has 7 warning signs investors should review. Among 569 Drug Manufacturers companies, Verano Holdings ranks worse than 65.55% on this metric.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Verano Holdings's Enterprise Value is $818.4 Mil.
Verano Holdings's Free Cash Flow for the trailing twelve months (TTM) ended in Jun. 2026 was $41.3 Mil. Therefore, Verano Holdings's EV-to-FCF for today is 19.82.
The historical rank and industry rank for Verano Holdings's EV-to-FCF or its related term are showing as below:
VRNOD'
s EV-to-FCF Range Over the Past 10 Years
Min: -1627.43 Med: 35.47 Max: 854.51
Current: 36.13
During the past 7 years, the highest EV-to-FCF of Verano Holdings was 854.51. The lowest was -1627.43. And the median was 35.47.
VRNOD's EV-to-FCF is ranked worse than 65.55% of 569
companies
in the Drug Manufacturers industry
Industry Median: 21.6
vs VRNOD: 36.13
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Verano Holdings's PE Ratio (TTM) for today is calculated as:
Verano Holdings's share price for today is $5.83.
Verano Holdings's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-3.555.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Verano Holdings EV-to-FCF Related Terms
Verano Holdings EV-to-FCF Historical Data
* Premium members only.
The historical data trend for Verano Holdings's EV-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Verano Holdings's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Verano Holdings EV-to-FCF vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Verano Holdings's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Verano Holdings's EV-to-FCF falls into.
Verano Holdings's current Enterprise Value is $818.4 Mil.
Verano Holdings's Free Cash Flow for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $41.3 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Verano Holdings (VRNOD) has a EV-to-FCF of 19.82 as of Aug. 08, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Verano Holdings and its competitors. This is 44% below median its historical median of 35.47. According to the industry distribution chart, Verano Holdings ranks #373 out of 569 companies in the Drug Manufacturers industry, placing it in the top 65.6%.
Is Verano Holdings' EV-to-FCF too high?
Verano Holdings' current EV-to-FCF of 19.82 is 44% below median its 10-year median of 35.47. The Drug Manufacturers industry median EV-to-FCF is 21.60. Verano Holdings' value of 19.82 is 8.2% below this industry median. Based on the distribution chart, Verano Holdings ranks #373 out of 569 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Verano Holdings has a GF Score™ of 73/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Verano Holdings' EV-to-FCF compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Verano Holdings ranks #373 out of 569 companies for EV-to-FCF. This places Verano Holdings in the lower half of its industry. The industry median EV-to-FCF is 21.60. Verano Holdings' value of 19.82 is 8.2% below this benchmark. While the company's 10-year median is 35.47 vs. the industry median of 21.60, Verano Holdings has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Drug Manufacturers company?
The median EV-to-FCF among Drug Manufacturers companies is 21.60, based on 569 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Verano Holdings's current EV-to-FCF of 19.82 is 8.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Verano Holdings and its competitors. For the Drug Manufacturers industry, the median EV-to-FCF is 21.60 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Verano Holdings's current EV-to-FCF is 19.82, which is 44% below median its own 10-year median of 35.47. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Verano Holdings stock overvalued right now?
Based on GuruFocus' analysis, Verano Holdings (VRNOD) is currently considered Modestly Undervalued. The stock's GF Value™ is $6.60, compared to a current price of $5.83 — trading 11.7% below its estimated fair value. The current EV-to-FCF is 19.82, which is 44% below median its 10-year median of 35.47 and 8.2% below the Drug Manufacturers industry median of 21.60. Verano Holdings' overall GF Score™ is 73/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For Verano Holdings (VRNOD), the current EV-to-FCF is 19.82 as of Aug. 08, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Verano Holdings (VRNOD) Overvalued in 2026?
Based on GuruFocus' analysis, Verano Holdings stock appears to be undervalued.
The current stock price of $5.83 is trading 11.7% below its estimated GF Value™ of $6.60.
GuruFocus considers Verano Holdings to be Modestly Undervalued.
Key valuation signals for VRNOD:
EV-to-FCF: 19.82 (44% below median its 10-year median of 35.47)
GF Value™: $6.60 vs. price of $5.83 (11.7% below fair value)
Industry Position: 8.2% below the Drug Manufacturers median (#373 of 569)
No single metric tells the full story. See the VRNOD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Verano Holdings Corp is a vertically integrated, multi-state cannabis operator in the United States. The company operates through cultivation (wholesale) and retail segments. Its consumer brands include Encore, Avexia, MUV, Savvy, BITS, and Verano, while its retail dispensaries operate under brands such as Zen Leaf and MUV. The company derives the majority of its revenue from the retail segment.
73GF Score
Get the complete analysis for VRNOD
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
VRNOD has been successfully added to your 
